Related Experiment Video
Updated: Aug 25, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Low-molecular-weight heparins in the cardiac catheterization laboratory
Rajan A Kadakia1, Shravantika R Baimeedi, James J Ferguson
1Department of Cardiology Research, Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, Texas 77225-0269, USA.
Insights
Low-molecular-weight heparins offer unique properties for percutaneous coronary intervention. This review discusses their use, monitoring, and future applications in anti-thrombotic therapy.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Low-molecular-weight heparins (LMWHs) are increasingly utilized in cardiovascular procedures.
- Their distinct pharmacokinetic and pharmacodynamic profiles necessitate specific clinical considerations.
Purpose of the Study:
- To review the unique properties of LMWHs.
- To examine the application of LMWHs in the catheterization laboratory for percutaneous coronary intervention (PCI).
- To discuss current and future research on LMWH use and monitoring.
Main Methods:
- Literature review of studies on LMWH properties and clinical use.
- Analysis of recent data on bedside monitoring of LMWH activity.
- Discussion of ongoing and future clinical trials.
Main Results:
- LMWHs possess unique properties making them suitable for PCI.
- Evidence supports the use of LMWHs in the catheterization laboratory.
- Bedside monitoring methods for LMWH activity are evolving.
Conclusions:
- LMWHs represent a valuable anti-thrombotic option for PCI.
- Further research will guide expanded clinical adoption.
- Clinicians should consider LMWHs for anti-thrombotic therapy in PCI.
Abstract:
We describe the unique properties of low-molecular-weight heparins and review studies of the use of these agents in the catheterization laboratory for percutaneous coronary intervention. Recent data regarding bedside monitoring of low-molecular-weight heparin activity are also discussed, as are ongoing and future studies that should be of assistance to clinicians as they consider expanding the use of this newer form of anti-thrombotic therapy.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization II: Right Heart Catheterization
Venous Thrombosis III: Interprofessional Care
